The Changing Role of Renal Mass Biopsy

The incidence and prevalence of small renal masses (SRMs) continues to rise and with increased detection comes increases in surgical management, although the probability of an SRM being benign is upward of 30%. An extirpative treatment first diagnose-later strategy persists and clinical tools for risk stratification such as renal mass biopsy remain severely underutilized. The overtreatment of SRMs has multiple detrimental effects including surgical complications, psychosocial stress, financial loss, and reduced renal function leading to downstream effects such as the need for dialysis and cardiovascular disease.

Source: Urologic Clinics of North America - February 20, 2023 Category: Urology & Nephrology Authors: Sohrab Naushad Ali, Zachary Tano, Jaime Landman Source Type: research